Vivopharm Holding ApS: Financial statements 2022
CVR: 41452935
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Vivopharm Holding ApS (CVR 41452935) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,181 and a net result of DKK -107,181 compared with DKK -6,250 the year before. Equity in the 2022 report amounted to DKK -19,681. The company had 1 employee in the financial year.
- Gross Profit
- DKK -7,181
- Profit/Loss
- DKK -107,181
- Equity
- DKK -19,681
- Total Assets
- DKK 0
- Employees
- 1
Official annual report
Keep an eye on Vivopharm Holding ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Vivopharm Holding ApS has published its annual report for 2021. Gross profit came to DKK -6,250, and the net result was DKK -6,250.
About Vivopharm Holding ApS
Vivopharm Holding ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Gert Mads Bolwig. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,131 and a net result of DKK -8,935 compared with DKK -8,097 the year before. Equity in the 2025 report amounted to DKK -44,186.